Pharma Mar Management
Management criteria checks 1/4
Pharma Mar's CEO is Jose Fernandez Sousa-Faro, appointed in Jan 1986, has a tenure of 38.25 years. directly owns 6.32% of the company’s shares, worth €33.22M. The average tenure of the management team and the board of directors is 13.1 years and 1.8 years respectively.
Key information
Jose Fernandez Sousa-Faro
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 38.3yrs |
| CEO ownership | 6.3% |
| Management average tenure | 13.1yrs |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
Pharma Mar, S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 03
Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden
Jan 25Pharma Mar, S.A. (BME:PHM) Shares Could Be 30% Below Their Intrinsic Value Estimate
Apr 28We Believe That Pharma Mar's (BME:PHM) Weak Earnings Are A Good Indicator Of Underlying Profitability
Mar 08Analyst Forecasts Just Became More Bearish On Pharma Mar, S.A. (BME:PHM)
Mar 05Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
Feb 09We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease
Oct 27An Intrinsic Calculation For Pharma Mar, S.A. (BME:PHM) Suggests It's 21% Undervalued
Sep 27Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?
Jul 15Growth Investors: Industry Analysts Just Upgraded Their Pharma Mar, S.A. (BME:PHM) Revenue Forecasts By 24%
May 04Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet
Apr 11There Is A Reason Pharma Mar, S.A.'s (BME:PHM) Price Is Undemanding
Mar 16Is Pharma Mar (BME:PHM) Using Too Much Debt?
Jan 09Pharma Mar (BME:PHM) Seems To Use Debt Quite Sensibly
Sep 08News Flash: Analysts Just Made A Meaningful Upgrade To Their Pharma Mar, S.A. (BME:PHM) Forecasts
Aug 03Here's Why I Think Pharma Mar (BME:PHM) Is An Interesting Stock
May 31Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
May 10Is Pharma Mar, S.A. (BME:PHM) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 08Announcing: Pharma Mar (BME:PHM) Stock Increased An Energizing 231% In The Last Five Years
Jan 14Is Pharma Mar (BME:PHM) A Risky Investment?
Nov 19CEO
Jose Fernandez Sousa-Faro
38.3yrs
Tenure
€294,000
Compensation
Mr. José María Fernández Sousa-Faro, Ph D., founded Pharma Mar, S.A.U. in 1986. He Founded Noscira, S.A., in 2000.He serves as the Chief Executive Officer and President of Pharma Mar, S.A.U. He serves as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 38.3yrs | €294.00k | 6.32% € 33.2m | |
| Executive Vice-Chairman | no data | €124.00k | no data | |
| Founder | no data | no data | no data | |
| Chief Financial Officer | 24.3yrs | no data | no data | |
| Director of Capital Markets & Investor Relations | 9.3yrs | no data | no data | |
| General Counsel & Secretary of the Board of Directors | 4.6yrs | no data | no data | |
| Global Compliance Head | 3.9yrs | no data | no data | |
| Communication Director | no data | no data | no data | |
| Director of Corporate Development | 2.3yrs | no data | no data | |
| Director of Human Resources & IT | 20.8yrs | no data | no data | |
| Managing Director of Oncology & Virology Business Units | 17yrs | no data | no data | |
| Chief Operating Officer of Pharmar U.S. | no data | no data | no data |
13.1yrs
Average Tenure
Experienced Management: PHM's management team is seasoned and experienced (13.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | no data | €294.00k | 6.32% € 33.2m | |
| Executive Vice-Chairman | no data | €124.00k | no data | |
| Independent Other External Director | 3.3yrs | €35.00k | 0.062% € 328.4k | |
| Independent Other External Director | no data | €35.00k | no data | |
| Proprietary Director | no data | €34.00k | 5.41% € 28.5m | |
| Independent Director | 5.3yrs | no data | no data | |
| Representative Proprietary Director | 3.3yrs | no data | no data | |
| Independent Director | 1.8yrs | no data | 0.0010% € 5.5k | |
| Independent Coordinating Director | 1.8yrs | no data | no data | |
| Independent Director | 1.8yrs | no data | no data | |
| Independent Other External Director | no data | no data | no data | |
| Independent Director | less than a year | no data | no data |
1.8yrs
Average Tenure
Experienced Board: PHM's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.